In a retrospective cohort study of hospitalized patients who received physostigmine to reverse an anticholinergic toxidrome what percentage of patients had no documented adverse effects?
182 (95.3%) patients
Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review. Clin Toxicol (Phila). 2018 Feb;56(2):101-107. doi: 10.1080/15563650.2017.1342828. Epub 2017 Jul 13. PMID: 28703024.
Contributed by: Florida/USVI Poison Information Center- Jacksonville, Toxicology Fellowship Program
Posted in Question Of The Day